🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
At present, there is no standard second-line treatment of refractory and re...
Status
Unknown
Location
he First Affiliated Hospital of Guangzhou Medical College
Start Date
2012-10
Trial ID
NCT01872416
Treatments Being Tested
The purpose of this study is to evaluate time to progression, overall survi...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00103506
Treatments Being Tested
This clinical trial is evaluating tucatinib in combination with Doxil in pa...
Status
Recruiting
Location
Maryland Oncology Hematology
Start Date
2023-07-24
Trial ID
NCT05748834
The French cooperative group GINECO proposes to implement an observational ...
Status
Completed
Location
Centre de Radiothérapie et d'Oncologie
Start Date
2014-07-10
Trial ID
NCT02163720
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This is a phase II, single arm, multi-centre study to assess the efficacy o...
Status
Active Not Recruiting
Location
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Start Date
2022-02-22
Trial ID
NCT04575961
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Unknown
Location
New England Medical Center Hospital
Start Date
1998-01
Trial ID
NCT00003296
Treatments Being Tested
The purpose of this study is to compare the effectiveness between CAELYX an...
Status
Terminated
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01840943
Treatments Being Tested